Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
The FDA broadened the use of BMS' CAR-T therapy Breyanzi to another type of blood cancer, where it'll again compete with Gilead and Novartis drugs.
Angus Liu
May 16, 2024 10:56am
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am
Pharma's reputation falls as pandemic-era halo slips
Apr 29, 2024 2:00am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Gilead enlists Raheem DeVaughn in HIV education, prevention work
Apr 12, 2024 7:10am